Erectile dysfunction (ED) affects many men with autoimmune diseases, though the relationship is complex and not always straightforward. Autoimmune conditions—where the immune system mistakenly attacks healthy tissues—can contribute to ED through chronic inflammation, vascular damage, hormonal imbalances, and psychological factors. The medications used to manage these conditions may also play a role. Understanding this connection is important: ED in men with autoimmautoimmune diseases is common, treatable, and discussing sexual health concerns with your GP is a vital part of comprehensive care. Early recognition and appropriate intervention can significantly improve quality of life and intimate relationships.

Understanding the Link Between Autoimmune Diseases and Erectile Dysfunction

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It affects a significant proportion of men with autoimmune diseases, though the relationship is complex and multifactorial. Autoimmune conditions occur when the immune system mistakenly attacks healthy tissues, leading to chronic inflammation and damage to various organs and systems. This inflammatory process can affect the vascular, neurological, and hormonal pathways essential for normal erectile function.

Research indicates that men with autoimmune diseases may experience ED at higher rates than the general population, with prevalence varying depending on the specific condition, disease severity, and duration. The connection is not always direct—autoimmune diseases may contribute to ED through multiple mechanisms, including vascular damage, chronic inflammation, hormonal imbalances, and psychological factors such as depression and anxiety associated with living with a chronic condition.

It is important to recognise that whilst there is an association between autoimmune diseases and erectile dysfunction, the relationship is not straightforward. ED in this context often results from a combination of the disease process itself, associated comorbidities (such as cardiovascular disease and diabetes), and the medications used to manage autoimmune conditions. The effects of corticosteroids, immunosuppressants, and certain disease-modifying antirheumatic drugs (DMARDs) on sexual function vary by agent, dose, and individual response, and the evidence is mixed and heterogeneous.

Understanding this connection is crucial for both patients and healthcare professionals. Men with autoimmune diseases should be aware that ED is a common and treatable complication, and discussing sexual health concerns with their GP or specialist is an important aspect of comprehensive disease management. Early recognition and appropriate intervention can significantly improve quality of life and intimate relationships.

Which Autoimmune Conditions Are Associated with Erectile Dysfunction?

Several autoimmune diseases have been linked to increased rates of erectile dysfunction, though the strength of association and quality of evidence vary between conditions.

Rheumatoid arthritis (RA) is one of the most studied autoimmune conditions in relation to ED. Studies suggest men with RA may experience ED at higher rates than age-matched controls, though estimates vary. The chronic inflammatory nature of RA, along with associated cardiovascular risk factors and the physical limitations imposed by joint disease, all contribute to this increased prevalence.

Systemic lupus erythematosus (SLE) affects multiple organ systems and is associated with significant vascular complications. Men with SLE may experience ED due to vasculitis (inflammation of blood vessels), accelerated atherosclerosis, and the effects of long-term corticosteroid therapy. The condition's impact on renal function and cardiovascular health further compounds the risk.

Sjögren's syndrome, characterised by immune-mediated damage to moisture-producing glands, has also been linked to sexual dysfunction, though the evidence base is more limited. Whilst more commonly discussed in relation to female sexual health, men with Sjögren's may experience ED related to the systemic inflammatory burden and associated fatigue.

Ankylosing spondylitis and other spondyloarthropathies can affect erectile function through chronic pain, reduced mobility, and the psychological impact of living with a progressive spinal condition. Studies suggest ED prevalence may be elevated in these conditions, though estimates vary and may reflect selection bias in smaller studies.

Type 1 diabetes, an autoimmune condition affecting insulin production, is well-established as a significant risk factor for ED. The combination of vascular damage, neuropathy, and metabolic disturbances creates multiple pathways to erectile dysfunction. Other conditions including inflammatory bowel disease (Crohn's disease and ulcerative colitis), psoriasis, and multiple sclerosis have also been associated with increased ED risk, though the mechanisms and prevalence vary.

How Autoimmune Diseases Affect Erectile Function

The mechanisms by which autoimmune diseases contribute to erectile dysfunction are diverse and often interconnected, involving vascular, neurological, hormonal, and psychological pathways.

Vascular dysfunction represents a primary mechanism. Erectile function depends on adequate blood flow to the penile tissues, and chronic inflammation associated with autoimmune diseases may accelerate atherosclerosis (hardening of the arteries) and damage the endothelium (inner lining of blood vessels). Inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) can impair nitric oxide production, a crucial molecule for vascular relaxation and penile erection. This process mirrors the vascular damage seen in cardiovascular disease, and ED is increasingly recognised as an early marker of systemic vascular health.

Chronic systemic inflammation may directly affect the smooth muscle tissue within the penis, reducing its ability to relax and allow blood engorgement. The persistent inflammatory state also contributes to oxidative stress, which damages cellular structures and impairs normal physiological responses.

Neurological involvement occurs in conditions such as multiple sclerosis, where demyelination affects nerve pathways controlling erectile function. In certain autoimmune conditions, chronic inflammation or associated vasculitis may lead to peripheral neuropathy, disrupting the neural signals necessary for achieving and maintaining an erection. The extent of neuropathy varies by condition and is not universal.

Hormonal imbalances are common in autoimmune diseases. Chronic inflammation and corticosteroid therapy can suppress testosterone production, leading to hypogonadism (low testosterone levels). Reduced testosterone affects libido, erectile function, and overall sexual satisfaction. Additionally, thyroid dysfunction, which may occur alongside other autoimmune conditions, can independently contribute to ED.

Psychological factors should not be underestimated. Living with a chronic autoimmune disease often involves pain, fatigue, reduced mobility, and concerns about body image. Depression and anxiety are significantly more prevalent in people with autoimmune conditions, and these mental health challenges directly impact sexual desire and function. The bidirectional relationship between psychological wellbeing and erectile function means that ED itself can worsen anxiety and depression, creating a difficult cycle.

Medication effects also play a role. Whilst treating the underlying autoimmune condition is essential, some medications may affect sexual function as a side effect, requiring careful discussion with healthcare providers about balancing disease control with quality of life.

Treatment Options for Erectile Dysfunction in Autoimmune Disease

Managing erectile dysfunction in men with autoimmune diseases requires a comprehensive approach addressing both the underlying condition and the specific factors contributing to ED.

Optimising autoimmune disease control is fundamental. Better management of the underlying condition—achieving disease remission or low disease activity—can improve vascular health, reduce systemic inflammation, and enhance overall wellbeing, all of which may positively impact erectile function. This should be undertaken in collaboration with rheumatologists or relevant specialists. Do not stop or change your immunosuppressant or DMARD treatment without specialist advice, as this may lead to disease flare.

Phosphodiesterase type 5 (PDE5) inhibitors remain the first-line pharmacological treatment for ED in men with autoimmune diseases. Medications such as sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Spedra) work by enhancing nitric oxide-mediated relaxation of penile smooth muscle, facilitating increased blood flow. These medications are generally safe and effective in this population, though efficacy may be somewhat reduced compared to men without chronic inflammatory conditions. NICE guidance supports their use as first-line therapy for ED of various aetiologies.

Before prescribing PDE5 inhibitors, your doctor should assess your cardiovascular risk (for example, using QRISK) and ensure any cardiovascular disease is stable. PDE5 inhibitors are contraindicated in men taking nitrate medications (used for angina) or riociguat (used for pulmonary hypertension) due to the risk of severe hypotension. Caution is required if you take alpha-blockers (for prostate symptoms or high blood pressure); your alpha-blocker dose should be stabilised before starting a PDE5 inhibitor at a low dose. Men should discuss their complete medication list with their GP before starting treatment.

Common side effects of PDE5 inhibitors include headache, flushing, indigestion, nasal congestion, and dizziness. Rare but serious side effects include sudden visual or hearing loss; seek urgent medical attention if these occur.

Lifestyle modifications play a crucial supporting role. Regular physical activity (adapted to individual capabilities), maintaining a healthy weight, smoking cessation, and limiting alcohol consumption all improve vascular health and erectile function. These interventions also benefit overall autoimmune disease management and cardiovascular health.

Psychological support should be considered integral to treatment. Cognitive behavioural therapy (CBT), couples counselling, or psychosexual therapy (available via your GP or sexual health clinics, and in some areas through NHS Talking Therapies) can address anxiety, depression, and relationship concerns that contribute to or result from ED. The psychological burden of chronic disease should not be overlooked, and addressing mental health often improves both sexual function and quality of life.

Testosterone replacement therapy (TRT) may be appropriate for men with confirmed symptomatic hypogonadism (low testosterone). Diagnosis requires symptoms (such as reduced libido, fatigue, low mood) and two morning total testosterone levels below the normal range, along with measurement of luteinising hormone (LH) and follicle-stimulating hormone (FSH). Testosterone replacement can improve libido, erectile function, mood, and energy levels. However, this requires careful monitoring (including prostate-specific antigen [PSA] and haematocrit) and is contraindicated in certain conditions, including prostate cancer and uncontrolled heart failure. Specialist input is often appropriate.

Alternative treatments for men who do not respond to oral medications include intracavernosal or intraurethral alprostadil injections (medications injected directly into the penis or inserted into the urethra), vacuum erection devices, and, in selected cases, penile prosthesis surgery. Alprostadil injections carry a risk of priapism (prolonged painful erection) and penile fibrosis; proper training and monitoring are essential. These options should be discussed with a specialist in sexual medicine or urology.

Medication review is essential. If current treatments for the autoimmune condition are suspected of contributing to ED, discussing alternatives with the prescribing specialist may be worthwhile, though disease control should remain the priority.

If you experience a suspected side effect from any medicine, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

When to Seek Medical Advice About Erectile Dysfunction

Men experiencing erectile dysfunction in the context of autoimmune disease should feel empowered to seek medical advice, as ED is a common, treatable condition that significantly impacts quality of life and may indicate other health concerns.

Persistent or worsening ED warrants medical attention. Whilst occasional difficulty with erections is normal, consistent problems over a period of several weeks or months should prompt a consultation with your GP. Early intervention often leads to better outcomes and prevents the condition from affecting psychological wellbeing and relationships.

New-onset ED in men with autoimmune diseases may signal changes in disease activity or the development of complications. It can also be an early warning sign of cardiovascular disease, as the smaller blood vessels in the penis are often affected by atherosclerosis before larger vessels supplying the heart. NICE guidance recognises ED as a potential marker of cardiovascular risk, and assessment should include cardiovascular risk stratification (for example, using QRISK).

You should seek medical advice if:

• ED persists for more than a few weeks

• You experience sudden loss of erectile function

• ED is accompanied by other symptoms such as chest pain, shortness of breath, or leg pain (which may indicate cardiovascular problems)

• You notice reduced libido, fatigue, or mood changes (which may suggest hormonal imbalances)

• ED is causing significant distress or affecting your relationship

• You have concerns about your current medications affecting sexual function

Urgent medical attention is required if you experience a prolonged, painful erection lasting more than four hours (priapism), which is a medical emergency requiring immediate treatment to prevent permanent damage. Call 999 or go to A&E immediately.

When consulting your GP, be prepared to discuss your autoimmune condition, current medications, other health problems, lifestyle factors, and the nature and duration of erectile difficulties. Your doctor may perform a physical examination and arrange blood tests, which typically include:

• HbA1c or fasting glucose (to assess diabetes risk)

• Fasting lipid profile (cholesterol and triglycerides)

• Morning total testosterone (repeated if low, along with LH and FSH)

• Thyroid function tests (TSH) if symptoms suggest thyroid disease

• Prolactin if you have low libido or other features suggesting pituitary disease

Your GP will also assess your cardiovascular risk and may refer you to specialist services (endocrinology, urology, or sexual health clinics) if initial tests reveal abnormalities such as markedly low testosterone with low or normal LH/FSH, raised prolactin, or suspected pituitary disease.

Remember that discussing sexual health is a routine part of medical care. GPs are experienced in addressing these concerns sensitively and confidentially. Effective treatments are available, and seeking help is an important step towards improving both sexual function and overall health. If your GP practice has a particular clinician with an interest in men's health or sexual medicine, you may request to see them specifically. Alternatively, referral to specialist services, including urology or sexual health clinics, may be appropriate depending on the complexity of your situation.

Frequently Asked Questions